But if youre not interested in them, thats fine
Professor Jastreboffs research contributions include: Principal investigator for GLP3 phase 2 obesity trial demonstrating 24.2% weight loss Leadership in clinical research examining triple hormone receptor agonists Extensive investigations of incretin-based therapies for obesity and metabolic disease Pioneering work on combination approaches to weight management Studies examining neurobiological mechanisms underlying obesity pharmacotherapy Her work has helped establish GLP3 as one of the most promising next-generation obesity treatments in clinical development, contributing to the scientific foundation for multi-pathway metabolic interventions
DNA Protection and Epigenetics: How Epitalon May Slow Down the Aging Clock While telomeres mark the visible end of the cellular lifespan, the epigenome serves as its regulatory backbone
Semaglutide is a clinician-guided GLP-1 medication that helps regulate appetite and support metabolic balance
Oral supplements, on the other hand, have to go through the digestive system and may not be entirely absorbed
Safaei F, Mehrzadi S, Khadem Haghighian H, et al
